 The stock price of Emergent Biosolutions, a specialty biopharmaceutical company, has seen a fall of 15 over the last twenty-one trading days, while it is down 42 year-t0-date. EBS stock has had a tough year so far, with its manufacturing unit in Baltimore facing the heat after contamination of. 